NCT03055377View on ClinicalTrials.gov

N-Acetylcysteine for Youth Cannabis Use Disorder

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

192

Participants

Timeline

Start Date

August 3, 2017

Primary Completion Date

January 31, 2024

Study Completion Date

February 26, 2024

Conditions
Cannabis Use Disorder
Interventions
DRUG

N-acetyl cysteine

N-acetylcysteine 1200 mg twice daily for 12 weeks (administered orally)

DRUG

Placebo oral capsule

Placebo (matched in appearance to N-acetylcysteine to preserve double-blind) twice daily for 12 weeks (administered orally)

Trial Locations (1)

29403

Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT03055377 - N-Acetylcysteine for Youth Cannabis Use Disorder | Biotech Hunter | Biotech Hunter